Private hospital in Kolkata launches rooftop helipad for emergency services

Kolkata's Desun Hospital successfully conducted a trial run of its newly launched rooftop helipad with an Agusta 109 SP helicopter, enhancing emergency healthcare services. Approved by the DGCA, the helipad aims to provide critical care air ambulance services for patients across West Bengal, North-East, and Eastern India, ensuring faster medical intervention.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/jdTgMB9
via IFTTT

Read More

Halt illegal imports of refurbished medical gear: Drug regulator

India's drug regulator has instructed Customs to prevent the entry of refurbished medical devices, as these lack regulation under existing rules. This move addresses concerns about patient safety and supports domestic manufacturers. Imports are halted until a policy framework is established, impacting the pre-owned medical equipment market, which aids underserved regions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/X6MgLZr
via IFTTT

Read More

Competition Commission of India penalises investment manager of Goldman Sachs AIF for failing to notify Biocon deal

The Competition Commission of India has imposed a Rs 40 lakh penalty on Goldman Sachs AIMPL for not notifying the regulator about a deal involving optionally convertible debentures issued by Biocon Biologics. CCI ruled the deal was strategic and required prior approval.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Qp1iXRJ
via IFTTT

Read More

A Healthy Dialogue: Future of health sector cooperation under the Trump administration

India faces a complex health cooperation agenda with the incoming US administration. Key focus areas include trade in pharmaceuticals, pandemic preparedness, vaccine development, digital health, and climate resilience in health systems. Ensuring continued collaboration and addressing emerging challenges requires strategic planning and negotiation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/U3PgLjh
via IFTTT

Read More

Clear labelling of industrial & medical oxygen must, PMO tells health ministry

The Prime Minister's Office has instructed the health ministry to ensure proper labelling of oxygen cylinders to differentiate medical oxygen from industrial oxygen. This action follows concerns raised by lawmaker Ajeet Madhavrao Gopchade about the importance of quality medical oxygen to prevent infections and health complications in patients, especially post-pandemic.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/JNBEq85
via IFTTT

Read More

Japanese pharma Takeda launches innovation centre, eyes to onboard AI-driven talent

Takeda opens its first Innovation Capability Centre in Bengaluru, targeting to hire 750 professionals in AI, data science, and cybersecurity. The facility aims to advance AI in drug discovery, clinical trials, and patient care. The company plans to launch its Dengue vaccine in India by 2026 and expand its focus on inflammation, oncology, and rare conditions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/bRziwIJ
via IFTTT

Read More

Alembic Pharmaceuticals gets USFDA nod for generic antidepressant tablets

Alembic Pharmaceuticals has received final approval from the USFDA for its generic version of Brexpiprazole tablets, used in treating major depressive disorder and schizophrenia. The approval covers strengths from 0.25 mg to 4 mg, and the market size for these tablets is estimated at USD 2 billion for the year ending September 2024.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/0xuA6hD
via IFTTT

Read More

Tata Group and IISc partner to establish medical school to pioneer healthcare education and research

The Tata Group has partnered with the Indian Institute of Science (IISc) to establish the Tata IISc Medical School on the IISc Bengaluru campus with a contribution of Rs 500 crore. The school aims to integrate clinical research and medical education through innovative degree programs and global collaborations, focusing on various medical specialities.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/iRvts7U
via IFTTT

Read More

Quadria Capital buys 10% stake in pharma company Aragen Life Sciences for $100 million

Aragen Life Sciences secured a $100 million investment from Quadria Capital, selling a 10% stake at a $1.4 billion valuation. This funding supports strategic expansion to meet demand from US and European innovators. Aragen revenue for FY24 and FY25 is projected at Rs 1,675 crore and Rs 1,800 crore respectively.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FWuwnEJ
via IFTTT

Read More

Healthcare Industry seeks tax cuts on insurance premiums & increased budgetary allocation in Budget 2025

Industry experts expect the 2025 Union Budget to include reforms for the healthcare sector. They seek increased government spending, focus on preventive healthcare, tax uniformity, and better insurance policies. Stakeholders hope for measures to improve healthcare infrastructure, especially in rural areas, and initiatives to support urban low-income households and combat diseases like cervical cancer.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/iL8kEhr
via IFTTT

Read More

AIG Hospitals to invest Rs 800 crore in new oncology centre

AIG Hospitals is investing Rs 800 crore in a new dedicated oncology centre in Hyderabad, featuring the cutting-edge Proton Beam Therapy system from Belgium-based IBA. This marks a significant milestone in delivering advanced cancer care in India, especially for treating complex tumours near critical organs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/UYcDj8H
via IFTTT

Read More

Pharma lobby seeks 2-year extension of schedule M deadline

Pharma lobby group FOPE has requested the government to extend the compliance deadline for the revised Schedule M till December 31, 2026. This is to allow manufacturers time to make necessary upgrades. The government is currently considering a draft notification suggesting an extension until December 31, 2025, for smaller manufacturers.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GgZ8Np4
via IFTTT

Read More

Practo reports 22pc rise in revenue in FY24, GMV crosses Rs 3,500 crore

Practo, a health-tech platform, reported a 22% revenue growth to Rs 240 crore for the 2023-24 financial year, achieving a GMV of Rs 3,500 crore. The company reduced its losses to Rs 17 crore and had its first profitable quarter. Practo focuses on improving healthcare outcomes and expanding its presence in India and abroad.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/doc6tWS
via IFTTT

Read More

Kotak Strategic Situations Fund buys into Neuberg Diagnostics

Kotak Strategic Situations India Fund II has invested Rs 940 Crore in Neuberg Diagnostics to support its inorganic expansion and prepare for its IPO. Neuberg aims to enhance personalized medicine and integrated diagnostics, with a strong network and market leadership in India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/HFTo0Nl
via IFTTT

Read More

Navigating cardiovascular risk in people with type 2 diabetes mellitus

The prevalence of Type 2 Diabetes Mellitus (T2DM) is rising globally, increasing cardiovascular disease (CVD) risk. Effective management strategies should include comprehensive control of blood glucose, blood pressure, and lipid levels, lifestyle changes, and the use of anti-diabetic medications to reduce CV events.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tIOSKN1
via IFTTT

Read More

Budget 2025: Tax cuts, sops on Pharma Inc's wish list

Pharmaceutical and hospital sector executives are requesting higher public healthcare spending, R&D incentives, and tax exemptions on life-saving drugs in the upcoming Union budget. They want more oncology drugs to be tax-exempt and lower customs duties on essential medical equipment. Executives also propose incentives for AI research and standardization of GST rates on medical devices.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GN072sy
via IFTTT

Read More

India, Dominican Republic packaged deadly synthetic opioids into pills: US report warns of risks from online pharmacies

Nearly 35,000 online pharmacies worldwide are operating illegally, risking the distribution of ineffective or dangerous drugs, says the U.S. Trade Representative's report. The report highlights concerns about counterfeits from 19 countries and names notorious markets and platforms involved in such activities, particularly across Asia and the United States.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/7eCgToF
via IFTTT

Read More

US pharma major Eli Lilly and Co plans to establish new GCC in Hyderabad

US pharma company Eli Lilly plans to open a new global capability centre in Hyderabad by mid-2025. It will recruit over 1,000-1500 skilled workers, including technology engineers and data scientists. The centre will focus on expanding capabilities in automation, artificial intelligence, software product engineering, and cloud computing to support Lilly's global business.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yG7IeVz
via IFTTT

Read More

Centre may decide on rollout of Schedule M by next week

The government is set to decide on implementing the revised Schedule M for pharmaceutical products by next week. While pharma groups have requested a two-year extension, no formal feedback for this has been received. The health ministry's draft notification suggests a year's extension, with a deadline for comments until January 11.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/1VOwsL7
via IFTTT

Read More

Chemists’ apex body against RailTel’s plan to get bids from e-pharma

In a letter to the Union minister for Railways, AIOCD President JS Shinde said that e-pharmacies are operating illegally in the country. "The High Court has prohibited operations of online pharmacies. The Central Drugs Standard Control Organization (CDSCO) in its affidavit has admitted that there is no provision for online pharmacies in India at present under the Drugs and Cosmetics Act, 1940 or its rules," the letter said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/L0IGOaE
via IFTTT

Read More

HMPV: Drug supplies from China not likely to be affected by virus

Mehul Shah, pharma expert said the operations in China have not been affected and the situation is under control. "As we all know that this virus does not cause severity, trade is unlikely to get impacted," said another expert. India is dependent on China for all major essential medicines like paracetamol, anti acid (ranitidine), cardiovascular drugs (Sartans), anti diabetes drugs (metformin), antibiotic (ciprofloxacin, ofloxacin), vitamins (ascorbic acid), acetylsalicylic acid (aspirin), among others.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/u8qQ5Oz
via IFTTT

Read More

Botanic Healthcare raises Rs 250 crore from Stakeboat Capital & other investors

Botanic Healthcare, a nutraceutical maker based in Hyderabad, has successfully raised Rs. 250 crores in its latest equity funding round led by Stakeboat Capital, with participation from Abakkus Four2Eight Opportunities Fund and DS Group. The funds will support the company's aggressive expansion plans and growth targets in the global nutraceutical market.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/P6rS5hX
via IFTTT

Read More

Alkem Laboratories to sell Pithampur unit for Rs 149 crore

Alkem Laboratories Ltd agrees to sell its manufacturing facility in Pithampur, Madhya Pradesh, to Rubicon Research Ltd for Rs 149 crore via a slump sale. The transaction supports Alkem's strategy of optimizing manufacturing facilities. Rubicon will take over the development, manufacture, distribution, and sale of pharmaceutical formulations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dCGQWYx
via IFTTT

Read More

Zydus Lifesciences joins hands with CVS Caremark for diabetes drugs template formulary

Zydus Lifesciences Ltd enters an agreement with CVS Caremark to add Zituvio, Zituvimet, and Zituvimet XR tablets for diabetes treatment to CVS’s template formulary starting January 1, 2025. This collaboration validates Zydus' new drug applications portfolio and aims to improve access to high-quality medications for patients.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/VI0DlNE
via IFTTT

Read More

Biosimilar brand buy to help Intas Pharma take on biggies

In one of the biggest deals worldwide for a biosimilar brand, Ahmedabad-based Intas agreed to buy Udenyca-the brand name for medication pegfilgrastim-cbqv-from US-based Coherus BioSciences. Udenyca will be sold in the US by Accord BioPharma, the specialty division of Intas Pharma.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/NPaOJ0H
via IFTTT

Read More

Cipla rolls out mobile application for asthma screening

Cipla has launched a mobile app, CipAir, to facilitate early screening for asthma in India. The app addresses the significant asthma burden in the country, aiding in better diagnosis and treatment. Initially available on Android, it will soon be rolled out on iOS devices as well.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/4adTfgC
via IFTTT

Read More

Govt grants pharma industry 12-month extension for implementing revised Schedule M

The government has extended the deadline for pharma companies to implement updated quality standards by 12 months. This extension helps smaller manufacturers upgrade facilities and meet revised Schedule M requirements. The industry initially sought a two-year extension to address challenges. Firms must now comply with improved manufacturing practices by December 31, 2025.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tLxlnXP
via IFTTT

Read More

Study estimates about a quarter of Indian population can access stroke facility in an hour

A study finds that only a quarter of India's population can access a stroke rehabilitation centre within an hour. The research highlights the lack of facilities, with less than one ischaemic stroke centre per million people. Improvements in infrastructure are urgently needed to enhance treatment outcomes.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wPdXQHZ
via IFTTT

Read More

5,000 drug manufacturing units may miss Schedule M deadline, industry seeks extension

Nearly half of India's 10,000 drug manufacturing units might not meet the 2025 deadline for upgrading to revised Schedule M standards, risking closure. Currently, only 2,000 comply with good manufacturing practices. The industry seeks a two-year extension for improvements, but the government hasn't announced one yet. Audits and inspections may begin soon.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/oLR38V0
via IFTTT

Read More

India's first Robotic-assisted Paediatric Gait Trainer for physical rehabilitation launched

Genrobotics launched India's first robotic-assisted Paediatric Gait Trainer, G-Gaiter Paediatric. It aims to improve physical rehabilitation for children with mobility issues. The device uses advanced VR technology and interactive games for therapy. Health Minister Veena George announced its installation at SAT Hospital in Thiruvananthapuram, enhancing healthcare with technology.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/X0RHONz
via IFTTT

Read More

“Nothing to be alarmed”: Health Ministry eases fears as China battles surge in respiratory virus

China is seeing a surge in infections caused by human metapneumovirus (HMPV), mostly in children under 14. Despite the uptick, the Indian health ministry states there is no cause for alarm, with no substantial increase in respiratory outbreaks within the country and prepared healthcare systems.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ocJjpu
via IFTTT

Read More

DJ Group of Institutions attains net debt-free status

DJ Group of Institutions, despite the challenges following the founder's death and regulatory changes, has achieved financial stability under Rhitik Jassar's leadership, turning from a ₹215 crore debt to net debt-free status. Their financial discipline, operational excellence, and strategic financial management have garnered recognition and continued support from key banking partners.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/42TfP5W
via IFTTT

Read More

Big public health upgrade in works; govt hospitals could soon get more firepower

The National Essential Diagnostics List will work as a guide for health facilities in India. It suggests basic tests for village-level centres and more advanced tests for Ayushman Arogya Mandirs and primary health centres. These guidelines aim to improve timely diagnosis and treatment, especially in rural areas.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9T8lRzA
via IFTTT

Read More